StonvexLoading…
StonvexStonvexStonvexCore line items from UPWK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $787.78M | $769.33M | $689.14M | $618.32M |
Operating Income | $129.31M | $65.21M | $-11.26M | $-92.62M |
Net Income | $115.42M | $215.59M | $46.89M | $-89.89M |
EPS (Diluted) | $0.84 | $1.52 | $0.06 | $-0.69 |
Total Assets | $1.30B | $1.21B | $1.04B | $1.08B |
Total Liabilities | $669.26M | $636.24M | $656.47M | $831.37M |
Cash & Equivalents | $294.36M | $305.76M | $79.64M | $129.38M |
Free Cash Flow OCF − CapEx | $242.47M | $150.03M | $52.02M | $10.25M |
Shares Outstanding | 130.55M | 135.35M | 137.27M | 132.37M |